Skip to main content
Skip to main content
Postgrad Med J. 1982 Jun; 58(680): 380–381.
doi: 10.1136/pgmj.58.680.380
PMCID: PMC2426344
PMID: 6812036

Early onset life-threatening myelosuppression after low dose of intravesical thiotepa

Giancarlo Agnelli, Paolo Gresele, Maria de Cunto, and Albano del Favero
Copyright and License information PMC Disclaimer

Abstract

Intravesical instillation of thiotepa is a popular treatment for localized bladder carcinoma. The drug can enter the systemic circulation, and such absorption may be enhanced by extensive tumour infiltration or by a recent tumour resection. A case is reported of early onset life-threatening pancytopenia following an unusually low dose of the drug in a patient who had undergone a recent tumour resection.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (245K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 380
380
icon of scanned page 381
381
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Abbassian A, Wallace DM. Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol. 1966 Oct;96(4):461–465. [PubMed] [Google Scholar]
  • Bruce D, Edgcomb JH. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide. J Urol. 1967 Mar;97(3):482–485. [PubMed] [Google Scholar]
  • Drew JE, Marshall VF. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers. J Urol. 1968 Jun;99(6):740–743. [PubMed] [Google Scholar]
  • Hollister D, Jr, Coleman M. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma. JAMA. 1980 Nov 7;244(18):2065–2067. [PubMed] [Google Scholar]
  • JONES HC, SWINNEY J. Thiotepa in the treatment of tumours of the bladder. Lancet. 1961 Sep 16;2(7203):615–618. [PubMed] [Google Scholar]
  • Koontz WW., Jr Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma. Semin Oncol. 1979 Jun;6(2):217–219. [PubMed] [Google Scholar]
  • Pavone-Macaluso M, Caramia G, Rizzo FP. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours. Urol Int. 1971;26(5):379–387. [PubMed] [Google Scholar]
  • Tomiyama T. [Effects of intravesical instillation of antitumor agents on bladder cancer]. Nihon Hinyokika Gakkai Zasshi. 1972 Jul;63(7):497–518. [PubMed] [Google Scholar]
  • Veenema RJ, Dean AL, Jr, Uson AC, Roberts M, Longo F. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. J Urol. 1969 May;101(5):711–715. [PubMed] [Google Scholar]
  • Wescott JW. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder. J Urol. 1966 Dec;96(6):913–918. [PubMed] [Google Scholar]
Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group